@Cricket99238 Avatar @Cricket99238 Nkap80

Nkap80 posts on X about $iova, $aqst, $lly, $vktx the most. They currently have [------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [------] #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks finance technology brands countries cryptocurrencies automotive brands currencies social networks financial services nfl

Social topic influence $iova, $aqst, $lly, $vktx, $nvo, in the, data, $nvda, investment, $pfe

Top assets mentioned Iovance Biotherapeutics, Inc. Common Stock (IOVA) Eli Lilly and Company (LLY) Viking Therapeutics, Inc (VKTX) Novo-Nordisk (NVO) NVIDIA Corp. (NVDA) Pfizer, Inc. (PFE) TransMedics Group, Inc. Common Stock (TMDX) RAI Finance (SOFI) Merck & Co., Inc. (MRK) Hims & Hers Health, Inc. (HIMS) TG Therapeutics, Inc. (TGTX) Rocket Lab USA, Inc. Common Stock (RKLB) Crowdstrike Holdings Inc (CRWD) Trade Desk, Inc. (TTD) Cloudflare, Inc. (NET) Apple, Inc. (AAPL) MANTRA (OM) Amazon.com, Inc. (AMZN) Alphabet Inc Class A (GOOGL) Axon Enterprise, Inc. (AXON) Zscaler Inc (ZS) Shopify Inc (SHOP) Tesla, Inc. (TSLA) Home Depot, Inc. (HD) BEAM (BEAM) EPR Properties (EPR) Snowflake Inc. (SNOW) ShockWave Medical, Inc. (SWAV) AstraZeneca PLC (AZN) GSK plc (GSK) Palantir Technologies Inc. (PLTR) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Blackstone, Inc. (BX) GammaSwap (GS) Muhdo Hub (DNA) Magic Eden (ME)

Top Social Posts

Top posts by engagements in the last [--] hours

"@ajitosu You are the master of itπŸ‘πŸ‘πŸ‘"
X Link 2021-05-14T23:20Z [---] followers, [--] engagements

"@amitisinvesting Absolutely and buy more if you have the conviction. $NVDA is a prime example amongst many others. Downturns are a true test of your psychological makeup for being an investor in the market. Its breathtakingly addictive πŸ˜€"
X Link 2023-05-18T04:40Z [---] followers, [--] engagements

"@amitisinvesting Probably Better and but considerably cheaper than $CRWD and $ZS"
X Link 2023-05-23T23:23Z [---] followers, [---] engagements

"@MichaelRohland7 Nope for $SOFI"
X Link 2023-06-01T03:34Z [---] followers, [---] engagements

"@FromValue really enjoyed the deep dive on $TTD with the @chitchatmoney team. This is a fascinating company with a fantastic leader. Go CTVπŸ˜€"
X Link 2023-06-23T16:12Z [---] followers, [----] engagements

"@CCM_Ryan $NET $SHOP"
X Link 2023-06-28T02:50Z [---] followers, [--] engagements

"@amitisinvesting and this is a nothing burger for $AAPL while it will be a significant escalation for $SOFI. They are making a financial jugggernaut with all functionalities at one place. There is a reason why $GS wants to ship it out to someone else"
X Link 2023-07-02T05:02Z [---] followers, [--] engagements

"@convictionhold Looks like $OM is always up against FDA for its device. This particularly sounds a bit nefarious : "The other observation relates to the alleged promotion of Tablo for continuous renal replacement therapy for which Tablo is not cleared in the U.S." Thoughts"
X Link 2023-07-10T16:23Z [---] followers, [----] engagements

"@Beth_Kindig $TTD is a terrific one to hold for the long term πŸš€"
X Link 2023-07-18T15:03Z [---] followers, [--] engagements

"@MattFrankelCFP Maybe a stake in $TSLA or $HD"
X Link 2023-08-06T08:59Z [---] followers, [---] engagements

"@amitisinvesting I really struggle to under the business most for $DNA and how they will make money. Its time for them to show the true differentiation or be content with the fate similar to $ME"
X Link 2023-08-11T04:59Z [---] followers, [---] engagements

"@convictionhold Is $OM ever going to get out of its own way Apart from the name it hasn't done anything to provide spiritual sanity to my investment πŸ˜€. Just keeps sliding on a constant basis. Holding it for now but hope they can turn a leaf soon Product is very differntiating"
X Link 2023-08-23T20:01Z [---] followers, [---] engagements

"@Budgetdog_ Yeah its crazy that even in this high interest rate environment listings are so short lived. USA has a housing shortage problem and not sure how it gets better without more homes being built. Folks still want to move and buy"
X Link 2023-08-27T02:10Z [---] followers, [--] engagements

"@Budgetdog_ I like how they say you have more purchasing powerπŸ˜€. Cant imagine a bigger financial scam than credit cards"
X Link 2023-09-01T00:15Z [---] followers, [----] engagements

"@buyingincome $O $PFE $HD"
X Link 2023-09-10T18:01Z [--] followers, [---] engagements

"@amitisinvesting Nope just added more $SOFI πŸ˜€"
X Link 2023-09-19T22:18Z [---] followers, [---] engagements

"@SmatteringShow been really enjoying the show and the mailbag episodes are fantastic. Keep up the great podcasting folksπŸ‘"
X Link 2023-10-09T15:28Z [---] followers, [----] engagements

"@DataDInvesting Neither am I. Just the way the data has flown post earnings for this company. I continue to believe in @anthonynoto and @SoFi. This is a long term hold for sure"
X Link 2023-10-12T18:28Z [---] followers, [--] engagements

"@Budgetdog_ $10k in $O (nice 6% yield on top) $10k in $SOFI (looks tremendous) $10k in discretionary biotech investing. Not for the faint of heart πŸ˜€ $20K in $GOOG and $AMZN $10K in high quality gym equipment $40K Remaining in S&P500 index funds / T bills"
X Link 2023-11-24T16:09Z [---] followers, [---] engagements

"@West0_Cap Depends what your risk tolerance is"
X Link 2023-12-11T03:51Z [---] followers, [--] engagements

"@Brian_Stoffel_ Very interesting. Valuation is something I also care about a lot more now. But on $CRWD I am completely torn. What are your thoughts. Seems like a terrific growth company but the valuation is extremely rich and something that makes me wanna hold back purchasing. Thoughts"
X Link 2023-12-15T17:22Z [---] followers, [---] engagements

"@GeneInvesting $TGTX $IOVA $CKPT $CRBU $BEAM"
X Link 2023-12-27T17:32Z [---] followers, [--] engagements

"@SteveWagsInvest $VICI $EPR $O $PFE $JEPI $MO"
X Link 2023-12-30T08:59Z [---] followers, [---] engagements

"@GeneInvesting TILs will finally become a commercial reality with $IOVA @IovanceBio getting its first approval against melanoma in Feb2024. A totally new modality to treat solid malignancies. This may create more interest from $MRK to just buy them out (reckless prediction thoughπŸ˜€)"
X Link 2023-12-30T21:12Z [---] followers, [---] engagements

"@amitisinvesting Arent markets closed tomorrow"
X Link 2024-01-01T04:56Z [--] followers, [---] engagements

"@Budgetdog_ I am a bit surprised that there are no REITs in your list. Is that one purpose or you think the total return isnt as good Just curious"
X Link 2024-01-04T02:06Z [--] followers, [---] engagements

"@hayleyinvests $SNOW"
X Link 2024-01-05T01:29Z [---] followers, [--] engagements

"@JRogrow Would be interesting to see how they fair in [----]. I still think $AMZN and $GOOG can have a decent year while $NVDA does what it does πŸ˜€"
X Link 2024-01-09T15:44Z [--] followers, [--] engagements

"@GeneInvesting @RazorSharpDNA PFE due to their tie up with $BEAM"
X Link 2024-01-12T22:25Z [---] followers, [--] engagements

"@_OliverVenture T1D by $SANA was quite compelling but its had a huge move recently. Additionally I think a lot of cool stuff happening with allogenic CAR-Ts"
X Link 2024-01-14T04:02Z [---] followers, [---] engagements

"@HeroDividend No $AAPL πŸ˜€"
X Link 2024-01-15T17:59Z [---] followers, [---] engagements

"@Brian_Stoffel_ Love the company but the stock valuation gives me a BIG pause. I would certainly be interested in adding more but not at the nose bleed valuation at the moment. Definitely the top dog in the space along with companies like $PANW and $ZS"
X Link 2024-01-16T22:18Z [---] followers, [---] engagements

"@GeneInvesting Flipped for 49ersπŸ˜€"
X Link 2024-02-12T00:10Z [---] followers, [--] engagements

"@themotleyfool @MotleyFoolMoney $O $JEPI $EPR $PFE"
X Link 2024-02-12T04:06Z [---] followers, [---] engagements

"@SteveWagsInvest learn how to read a balance sheet"
X Link 2024-02-20T19:48Z [---] followers, [---] engagements

"@CCM_Ryan decent report out today. IMpressive revenue growth"
X Link 2024-02-23T01:34Z [---] followers, [--] engagements

"@Biotech2050Pod @bioagelabs @aloktayi Very intriguing discussion and was very interesting to learn about how big companies like $LLY are thinking about continuously updating / optimizing their weight loss franchise. Keep up the great podcastingπŸ‘"
X Link 2024-02-27T00:20Z [---] followers, [--] engagements

"@Pharmdca You might find this private biotech quite interesting They are collaborating with $LLY to test out a combination drug for weight loss. The science is quite intriguing. Thought will share with you"
X Link 2024-02-27T00:23Z [---] followers, [--] engagements

"@PhDVoice @PostdocVoice Choose a different PI"
X Link 2024-02-29T15:44Z [---] followers, [---] engagements

"@Pharmdca But they are nowhere close to having the capacity to manufacture at the moment. I like your enthusiasm but completely discounting the work that $LLY and $NVO will do in the interim before Viking gets its approval seems a bit presumptuous"
X Link 2024-03-01T04:47Z [---] followers, [---] engagements

"@ftr_investors $SE should be interesting. After what happens to Palo Alto and ZS interested to see the response to $CRWD"
X Link 2024-03-02T18:26Z [---] followers, [---] engagements

"@HeroDividend spotify. easy"
X Link 2024-03-24T00:20Z [---] followers, [--] engagements

"@drchekkers @AndrewDudum @TheLancetPsych @TheLancet @YaleMed @NHSEngland @srchekroud @hmkyale @Mental_Elf @YalePsych very interesting work. Any interest / bandwidth at also looking at biomarkers and their impact on longevity and not just mental health I am very intrigued the impact of duration of exercise on mental health. fascinating"
X Link 2024-03-29T17:29Z [---] followers, [--] engagements

"@chitchatstocks $RBLX"
X Link 2024-03-29T20:05Z [---] followers, [---] engagements

"@HolySmokas $AXON"
X Link 2024-04-08T21:11Z [---] followers, [---] engagements

"@JonahLupton $SOFI πŸ˜€"
X Link 2024-04-12T23:31Z [---] followers, [--] engagements

"@InvestInAssets $TMDX $AXON"
X Link 2024-04-15T01:35Z [---] followers, [---] engagements

"@Brian_Stoffel_ really love what the company is trying to achieve and somehow reminds me of the success of $SWAV. I can certainly see them being a top dog in this space. Such a massive opportunity with a huge runway ahead. Do you know if they are adding any more organs (heart) to the list"
X Link 2024-05-01T17:34Z [---] followers, [---] engagements

"@Brian_Stoffel_ Valuation has always been a problem for this company. I would happily own a 20% y/y revenue growth company but the current P/S gives me a pause to add more. I will hold the shares for the time being but similar to you wait and watch the growth. SBC looks decent not excessive"
X Link 2024-05-03T17:53Z [---] followers, [---] engagements

"@chitchatstocks $SNOW"
X Link 2024-05-23T02:34Z [---] followers, [---] engagements

"@CCM_Brett @chitchatstocks Their guide down on margins but I think once you start looking at R&D expenses and product revenue growth in totality its quite obvious. I think its an interesting company long term with some of the key metrics quite inflated. But the FCF margins are good and they look strong"
X Link 2024-05-23T05:44Z [---] followers, [--] engagements

"@Pharmdca should learn from $NVDA and do a stock split to accelerate the march to 1KπŸ˜€"
X Link 2024-05-24T19:46Z [---] followers, [--] engagements

"@prosperousguy at this point its just a free fall. Everyday is a RED day for this one unfortunately. Hopefully the ASCO presentation will stoke some confidence into this beaten down biotech"
X Link 2024-05-28T19:16Z [---] followers, [--] engagements

"@Brinkswealth10 @GreedyHuat @EsperionInc Next earnings call should be interesting. Do we know when they start selling in EU"
X Link 2024-06-01T14:15Z [---] followers, [--] engagements

"@BIOTECHSCANNER yes but this is beginning to look quite precarious despite strong data. Do you think the $MRNA data has something to do with weakness around the share price. I still think long term $IOVA should be fine and $MRK might be the one that takes it out. TILVANCE-301 data is imp"
X Link 2024-06-03T17:48Z [---] followers, [---] engagements

"@Pharmdca somehow recall even $PFE had tolerability issues leading them to discontinue their study"
X Link 2024-06-03T20:31Z [---] followers, [---] engagements

"@VMECAP @MoneyPigTrading What makes you think a BO is imminent"
X Link 2024-06-05T00:05Z [---] followers, [--] engagements

"@Brinkswealth10 The fireside chat at Jeffries was so refreshing and bullish. I am surprised that it continues to be so undervalued. The next earnings should be πŸ”₯πŸ”₯πŸ”₯. Long $ESPR"
X Link 2024-06-07T15:48Z [---] followers, [---] engagements

"@DvdndDiplomats $PFE"
X Link 2024-06-10T01:00Z [---] followers, [--] engagements

"@Pharmdca How do you feel about $LLY chances of trumping them with their oral formulation A trial in india makes a lot of sense an would catapult them into a HUGE target population in need of these oral pills. https://www.clinicaltrialsarena.com/news/eli-lilly-weight-drug-india/cf-view https://www.clinicaltrialsarena.com/news/eli-lilly-weight-drug-india/cf-view"
X Link 2024-06-18T22:25Z [---] followers, [---] engagements

"@Brinkswealth10 This is pure irrationality. Such a tremendous opportunity to build a decent position and let them compound their growth"
X Link 2024-06-21T07:57Z [---] followers, [--] engagements

"@Pharmdca India England should be a cracker. I really hope kohli can shine. Must be hurting to not have scored In a WC"
X Link 2024-06-25T05:35Z [---] followers, [--] engagements

"@Budgetdog_ Stocks because of the diversity and ease of liquidity. Plus its fun reading and learning about businesses and how they make money"
X Link 2024-07-15T01:24Z [---] followers, [--] engagements

"@chitchatstocks @finchat_io If that were the case then why are the comps declining so much. I think folks are getting tired to paying such high prices at $MCD. At these levels you an have a comparable meal at Chick-fil-A or chipotle"
X Link 2024-07-30T17:21Z [---] followers, [--] engagements

"@InvestingPod Wondering what you guys think of the "wonderful" price action in $OM. Does it make sense to you and were the results so bad that the company lost 2/3rd of its market cap"
X Link 2024-08-09T19:34Z [---] followers, [--] engagements

"@Brinkswealth10 But wouldnt that be a cop out. If the company can scale its salesforce and dominate the space then why would they want to sell the company at such depressed prices Even at 3x the market cap its just past a $1B company which is extremely low. I hope they can scale the sales"
X Link 2024-08-17T01:04Z [---] followers, [---] engagements

"Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial . Landmark results from a company that's headed to become the first $1T market cap biotech company in the world. What amazing results Go $VKTX https://cnb.cx/4dAdcFC https://cnb.cx/4dAdcFC"
X Link 2024-08-20T14:41Z [---] followers, [---] engagements

"@StockMarketNerd $SHOP"
X Link 2024-08-20T16:50Z [---] followers, [---] engagements

"@BIOTECHSCANNER You should seriously work for their PR team πŸ˜€. I dont think I have ever seen someone make a case for drugs stability to overcome extreme car temperatures πŸ˜‚"
X Link 2024-08-20T23:08Z [---] followers, [---] engagements

"@chitchatstocks @paulcerro @CCM_Brett I would be very much interested in knowing his thoughts on $HIMS providing compounded formulations for GLP-1 drugs and fears around its administrations / side effects. I think this could a HUGE windfall for $HIMS that is not even factored appropriately into their growth story"
X Link 2024-08-21T15:52Z [---] followers, [---] engagements

"@StockMarketNerd Shouldnt the $AMD report give us confidence that $NVDA will beat and raise I am very curious to see what Jensen says during the call. πŸ”₯πŸ’ͺ"
X Link 2024-08-25T23:08Z [---] followers, [---] engagements

"@StockMarketNerd They really need to control the SBC and I dont like how much they are going to buyback just to manage dilution"
X Link 2024-08-26T15:26Z [---] followers, [---] engagements

"@sidecarcap CEO of Constellation Software /: Mark Leonard"
X Link 2024-09-11T18:23Z [---] followers, [---] engagements

"@KoyfinCharts $SOFI $HIMS $RKLB"
X Link 2024-09-27T21:59Z [---] followers, [---] engagements

"@Pharmdca At these levels and with their data $MRK could easily put 100-150M into the company and let them move forward at pace"
X Link 2024-10-02T23:38Z [---] followers, [---] engagements

"@fluffer9 The only issue is the long wait to performing P3 filing BLA and getting an approval followed by commercialization. In the meantime the big boys $LLY $NVO will continue to dominate the markets. $VKTX def has a BIC safety and efficacy profile so maybe a possible BO "
X Link 2024-10-04T18:24Z [---] followers, [---] engagements

"@mvcinvesting A business on the ascendancy and building a strong monopoly. Somehow thinking of $TMDX reminds me of $AXON in the early days. $TMDX can really own this space and revolutionize the whole organ transplant landscape and efficiency to save 1000s of lives"
X Link 2024-10-08T00:51Z [---] followers, [----] engagements

"@chitchatstocks It has become quite the battleground stock"
X Link 2024-10-09T04:08Z [---] followers, [--] engagements

"@chitchatstocks Fabulous deep dive into a very interesting opportunity. Thanks for doing the due diligence on this tickerπŸ™ŒπŸ‘πŸ‘Œ"
X Link 2024-10-10T14:49Z [---] followers, [--] engagements

"@StockMarketNerd maybe an idea where $TTD is already providing service πŸ˜€"
X Link 2024-10-19T21:45Z [---] followers, [---] engagements

"@StockSavvyShay $OM"
X Link 2024-10-20T22:18Z [---] followers, [---] engagements

"A timely reminder of the massive opportunity that lies ahead for $TMDX to capture. And this is the not even including Kidney transplants which could be a huge component in the future as they continue to iterate expand and lead with their OCS system. πŸ’ͺπŸ‘"
X Link 2024-10-22T16:24Z [---] followers, [----] engagements

"@StockMarketNerd And even if we can print and do all the heavy lifting I feel it should benefit $TMDX as their OCS could be used for transportation and maintenance of these organs"
X Link 2024-10-22T21:24Z [---] followers, [---] engagements

"@StockMarketNerd really interested in hearing what the company has to say. Been a bit beat down of late but one of the best monopolistic bets out there after $AXON. I think $TMDX will report good numbers and show strong growth"
X Link 2024-10-28T16:51Z [---] followers, [----] engagements

"@Pharmdca for a high growth business any sort of slowdown or revenue miss is always looked upon as "End" of story. I still think 64% revenue growth is tremendous and personally for me this is a business with strong moat and will be much bigger 3-5 years out. Long $TMDX"
X Link 2024-10-28T21:11Z [---] followers, [---] engagements

"@mvcinvesting [--]. $AMZN [--]. $NVDA [--]. $TSLA [--]. $META [--]. $GOOG [--]. $MSFT [--]. $AAPL"
X Link 2024-10-31T22:13Z [---] followers, [---] engagements

"@BIOTECHSCANNER $IOVA should start getting shuttled like a penny stock once they report the next ER. Its such a differentiated product and if they either become a first line treatment in Melanoma and/or also have a strong readout in NSCLC it should πŸš€πŸš€πŸš€. Patience is warranted"
X Link 2024-11-01T15:15Z [---] followers, [----] engagements

"@Pharmdca The $AZN data has been a downer for $VKTX but I am amazed that BP would be willing to shell out billions for one asset while $VKTX has a pipeline of blockbuster assets. Long $VKTX and this is a wonderful opportunity and a timely reminder of why investing in biotech is tough"
X Link 2024-11-04T16:34Z [---] followers, [---] engagements

"@IBD_AGatlin Looks like market is spooked by the $AZN results"
X Link 2024-11-04T16:43Z [---] followers, [--] engagements

"@mvcinvesting Interesting but with the $NVO exec getting on board I am surprised that they dont have access to ozempic/wegovy. Maybe $NVO is keeping their price possession close to chest for now πŸ˜€"
X Link 2024-11-05T01:03Z [---] followers, [---] engagements

"@Pharmdca hopefully $SOFI can replace it soon πŸ˜€"
X Link 2024-11-14T17:39Z [---] followers, [---] engagements

"@BIOTECHSCANNER What are your thoughts on $CRVS already being miles ahead in the clinical development program for AD Maybe a topical solution has a better safety profile but not sure how differentiated that asset it especially with $CRVS about to initiate their Phase [--] study on AD"
X Link 2024-11-14T17:41Z [---] followers, [---] engagements

"@Pharmdca I believe one needs [--] qtrs of profitable growth to be added to S&P500 which $SOFI will have by the next EC"
X Link 2024-11-14T17:54Z [---] followers, [--] engagements

"@BIOTECHSCANNER Yes you are right. I mixed the indications. Thanks for keeping me honest πŸ˜€. $AQST looks an amazing one to own over the next 12-15 mo and hopefully longer time frame"
X Link 2024-11-14T18:13Z [---] followers, [---] engagements

"@mvcinvesting I always hear that $HIMS in only selling liraglutide (off patent) and not simaglutide. Do we have confirmation that its the latter since even the $NVO CEO has come out and said that theyre dont sell it to compounding facilities currently. Thanks for the deep diveπŸ‘ŒπŸ»"
X Link 2024-11-16T15:56Z [---] followers, [----] engagements

"@StockSavvyShay $CAVA"
X Link 2024-11-16T20:40Z [---] followers, [---] engagements

"@Pharmdca and ideal for $VKTX with the same drug for both administrations. Such an undervalued company. And that is not even taking into account the rest of the pipeline. Patience in warranted"
X Link 2024-11-19T18:32Z [---] followers, [---] engagements

"@mvcinvesting can't wait for neutron to launch in a couple of quarters. What a moment that would be"
X Link 2024-11-25T18:03Z [---] followers, [---] engagements

"@semodough Maybe a partnership with $IOVA could be synergisticπŸ˜€"
X Link 2024-12-04T15:45Z [---] followers, [---] engagements

"@mvcinvesting $HIMS or $ESPR"
X Link 2024-12-09T00:42Z [---] followers, [----] engagements

"@elaineywchen $LLY is going after so many Large indications using just the GLP-1/GIP dual agonists. They will most likely be the first $1T pharma"
X Link 2024-12-10T19:26Z [---] followers, [--] engagements

"@StockMKTNewz databricks"
X Link 2024-12-10T19:26Z [---] followers, [--] engagements

"@Investingcom $SOFI"
X Link 2024-12-14T23:26Z [---] followers, [---] engagements

"@isaac_kelso Why not $MRK"
X Link 2024-12-26T13:13Z [---] followers, [---] engagements

"@StockSavvyShay $SOFI"
X Link 2024-12-27T02:08Z [---] followers, [---] engagements

"@Mufaso7 Do you have any sense of the efficiency of their manufacturing process As without that just lower overall requirement wont be that big a deal given how much investment $LLY is making to increase its capacity. Safety is certianly a big advantage but $LLY has such a jump start"
X Link 2024-12-29T10:43Z [---] followers, [---] engagements

"@bhogleharsha I am sure even Rohit realizes that he cant justify a place in the playing [--]. Come on. Step aside and let the younger generation get a feel for playing in Australia"
X Link 2024-12-30T01:59Z [---] followers, [--] engagements

"@DataDInvesting Thanks as always for your due diligence. History may not repeat but it sure as hell with Rhyme for these folks when $SOFI repeats a top-line beat again in a few weeks time. Don't miss the forest for the tress. Just another day in the Stock market"
X Link 2025-01-02T18:24Z [---] followers, [----] engagements

"@GeneInvesting $IOVA $ESPR $PDSB"
X Link 2025-01-03T16:38Z [---] followers, [----] engagements

"@DataDInvesting These reports are only validation for the long term value this company is creating. Stay calm and stay invested. Thanks for all your due diligence around this amazing business"
X Link 2025-01-03T23:57Z [---] followers, [---] engagements

"@mvcinvesting Many gems in the biotech space as its a badly beaten sector. I really hope the deal flow comes back and there is more M&A in this sector to kick start 2025"
X Link 2025-01-05T16:08Z [---] followers, [----] engagements

"@PharmDabbler $TGTX could be worth a look"
X Link 2025-01-06T22:48Z [---] followers, [---] engagements

"@Mufaso7 have you looked at Verdiva Bio which seems to have a once weekly oral formulation for its weight loss drug They just raised a whopping $410M series A https://www.businesswire.com/news/home/20250108537646/en/Verdiva-Bio-a-New-Clinical-Stage-Cardiometabolic-Company-Launches-with-Over-410M-in-Series-A-Financing-to-Advance-Next-Generation-Therapies https://www.businesswire.com/news/home/20250108537646/en/Verdiva-Bio-a-New-Clinical-Stage-Cardiometabolic-Company-Launches-with-Over-410M-in-Series-A-Financing-to-Advance-Next-Generation-Therapies"
X Link 2025-01-10T22:17Z [---] followers, [---] engagements

"Maybe a possible mechanistic reason why TILs cultured outside the body are better at countering cancer cells upon re-injection . THis is fascinating and underappreciated biology. Go $IOVA #TILs https://www.nature.com/articles/d41586-025-00176-2 https://www.nature.com/articles/d41586-025-00176-2"
X Link 2025-01-22T23:06Z [---] followers, [---] engagements

"@MotleyFoolMoney Even though this sector is discussed rarely on the podcast I would be interested in listening to your thoughts in general on the elongated slump in the biotech world. With even the large pharma like $PFE $MRK $GSK struggling to hold their ground will this ship ever turn"
X Link 2025-03-04T20:56Z [---] followers, [---] engagements

"@Ask_WellsFargo @WellsFargo When a customer wants to close their accounts please let them do it. Don't drag it out to [--] months suggesting nonsensical reasons for still maintaining these accounts while providing no clarity. Do better and be of help"
X Link 2025-03-05T18:26Z [---] followers, [--] engagements

"@BIOTECHSCANNER @sgonza33 There is certainly activity in this space as an oral or patch based delivery could be a HUGE needle mover for any company : https://www.biospace.com/press-releases/anodyne-nanotech-achieves-breakthrough-in-transdermal-delivery-of-glp-1-drugs https://www.biospace.com/press-releases/anodyne-nanotech-achieves-breakthrough-in-transdermal-delivery-of-glp-1-drugs"
X Link 2025-03-06T17:10Z [---] followers, [---] engagements

"@BIOTECHSCANNER @sgonza33 and I think this is possibly one of the many reasons along with market meltdown for the fall in $AQST shares today. Long term they have a BIC and FIC game changing product for sure. https://snacksafely.com/2025/03/fda-approves-neffy-for-young-kids/ https://snacksafely.com/2025/03/fda-approves-neffy-for-young-kids/"
X Link 2025-03-06T17:23Z [---] followers, [---] engagements

"@BIOTECHSCANNER thoughts you might find this useful. Time for $AQST to get approval and commercialization of anaphylm to save the vulnerable souls"
X Link 2025-03-18T16:03Z [---] followers, [--] engagements

"@BIOTECHSCANNER volatility wrapped in patience is the price one pays for investing in biotechs. This sector has been badly beaten and hopefully companies like $AQST contribute towards reversing the trend to the upside"
X Link 2025-03-19T04:12Z [---] followers, [---] engagements

"@BIOTECHSCANNER $ABBV should be very interested in this asset I presume"
X Link 2025-03-19T15:20Z [---] followers, [---] engagements

"@StockMarketNerd $NVDA $LLY"
X Link 2025-03-25T14:23Z [---] followers, [---] engagements

"@turbotax Such terrible service after you charge customers full fees while your customer service is unable to provide resolution / guidance on some basic queries. Please do better to make your long standing customers continue to use your services. Very disappointed"
X Link 2025-04-07T22:29Z [---] followers, [--] engagements

"@FromValue $MELI"
X Link 2025-04-19T04:53Z [---] followers, [---] engagements

"@DataDInvesting $HIMS $SHOP and $NET. Also since I hold $LLY I am very interested in seeing what $NVO reports and their possible commentary on tie up with $HIMS to sell wegovy. I am not sure how I feel about this deal from $NVO's point of view but this should be material for $HIMS"
X Link 2025-05-05T04:09Z [---] followers, [---] engagements

"@StockMarketNerd maybe they are getting to load some $SOFI πŸ˜ƒ"
X Link 2025-05-15T22:54Z [---] followers, [---] engagements

"@BIOTECHSCANNER Maybe I have missed this detail but has $IOVA ever shown any data to suggest that TILs from heavily pretreated patients are worse than those undergoing first line of treatment Once they are isolated they are expanded in vitro before being administered so why the difference"
X Link 2025-05-31T23:31Z [---] followers, [---] engagements

"@BIOTECHSCANNER Thanks for the responses. Your recent deep dives into this ticker has Certianly reinforced my thesis to hold this one for the foreseeable future. Such a differentiated and unique assetπŸ‘ŒπŸ»πŸ’ͺπŸ‘"
X Link 2025-06-01T01:55Z [---] followers, [---] engagements

"@BIOTECHSCANNER @TheRealDanSfera I really hope your revenue projections are achieved as that would be incredible. I am eagerly awaiting the next earnings call along with the NSCLC update. Many irons in the fire for this badly beaten ticket"
X Link 2025-06-12T06:46Z [---] followers, [---] engagements

"@DataDInvesting @CNBC Waiting for @AndrewDudum to release a statement and what could have been done to avoid this mishap. Its Certianly not a good look for $HIMS today and the stock is getting whacked as expected"
X Link 2025-06-23T16:12Z [---] followers, [---] engagements

"@Pharmdca And even then I think $LLY will dominate. Economies of scale and they have the might. Maybe someone will scoop $VKTX to compete against them"
X Link 2025-06-26T04:04Z [---] followers, [---] engagements

"@MichaelVaughan India doesnt need @Jaspritbumrah93 as long as England keeps gifting wickets. Match nicely poised and if @benstokes38 goes soon this is game on for India"
X Link 2025-07-13T14:50Z [---] followers, [--] engagements

"@mvcinvesting If the neutron launch is successful even these estimates will feel utterly conservative. After SpaceX (valued almost at $400B) I think they are the only true full stack space economy pure play. Long $RKLB and I believe in the vision of @Peter_J_Beck"
X Link 2025-07-14T15:57Z [---] followers, [---] engagements

"@foundmyfitness @BenBikmanPhD What an incredible episode on one of the core scientific principles - Insulin Resistance. Intriguing findings and its health impact. Inspired by the discourse I bought the book and will be reading it with my eyes wide open. Thanks for creating such wonderful and useful contenπŸ‘"
X Link 2025-07-29T15:15Z [---] followers, [---] engagements

"@mvcinvesting In 5-7 years these prices could look like an absolutely steal. Long $RKLB and I believe in their visionary CEO. Neutron will be a step function in the trajectory of this company"
X Link 2025-08-06T02:02Z [---] followers, [---] engagements

"@rumourbuyouts $5 would be such a shame and undervaluation for a company that is beginning to ramp up sales already at nett market cap value. With profitability just a couple of quarters away anything less than $1.5-2B MC would be travesty for this company"
X Link 2025-08-11T19:10Z [---] followers, [---] engagements

"@MaryBschanck Definitely a name to keep high on the conviction list. Great execution so far and still looks to have a loooooong runway ahead Go $TGTX πŸ‘ŒπŸ»πŸ™ŒπŸ»πŸ’ͺ🎢"
X Link 2025-08-13T01:12Z [---] followers, [---] engagements

"@Pharmdca $ESPR $TGTX $VKTX $IOVA $SLDB"
X Link 2025-08-13T01:23Z [---] followers, [---] engagements

"@HyperTechInvest $AXON. Pure monopoly and vertically integrated business"
X Link 2025-08-13T01:29Z [---] followers, [---] engagements

"@EndicottInvests I thought there already had a deal with $NET"
X Link 2025-08-22T06:18Z [---] followers, [---] engagements

"@BIOTECHSCANNER Iovance need a better operational officer for sure. Cant afford to miss guidance again. That would be blasphemous. So much value and such poor execution. Might also help to have a full time ceo. The interim role has gone on for way too long"
X Link 2025-08-29T04:53Z [---] followers, [---] engagements

"@BIOTECHSCANNER $AQST seems a no brainer investment to me. They have the most complete data package I have ever seen for a life saving product"
X Link 2025-09-04T01:25Z [---] followers, [---] engagements

"@WilliamGreen72 Such a simple and clear understanding of the business gyrations. If one wants to experience compouding then navigating the topsy turvy landscape of the investing timeline is the only way. Believe in your convictions and add to businesses generating FCF/share positive value"
X Link 2025-09-04T20:41Z [---] followers, [---] engagements

"@BIOTECHSCANNER Even after this move $AQST looks so cheap especially now that the biggest overhang has been removed. Don't be short sighted on this one. This is a life saving product at the tip of your fingertips. No clunky devices. Just pure simple administration of a life saving drug πŸ’Š"
X Link 2025-09-05T17:53Z [---] followers, [---] engagements

"@mvcinvesting Incredibly grateful for your due diligence on this gemπŸ™"
X Link 2025-09-08T21:27Z [---] followers, [---] engagements

"@AnjKhem No but they also cant afford to stay on the sidelines of the biggest drug class of all time. That being said they wont be in the market till [----] so maybe a company like $VKTX would have made more sense with an ongoing phase [--] already"
X Link 2025-09-22T16:05Z [---] followers, [---] engagements

"@BIOTECHSCANNER $IOVA is an absolute dog of a stock. I am hoping the data readouts and the next EC will turn the tide for this massively beaten down biotech"
X Link 2025-09-25T21:35Z [---] followers, [---] engagements

"@BIOTECHSCANNER Thanks for the great updates but do we know if similar to Melanoma $IOVA may have plans to initiate a 1L treatment w/ or w/o Keytruda in NSCLC I only see studies in this indication post PD-1 administration. https://www.iovance.com/clinical-pipeline/ https://www.iovance.com/clinical-pipeline/"
X Link 2025-10-09T16:36Z [---] followers, [---] engagements

"@hubermanlab What an absolutely tour de force episode. I will be listening to this many times over as there are so many practical and at times suprsingly contrarian considerations for a healthy and STRONG physiology"
X Link 2025-10-15T20:43Z [---] followers, [--] engagements

"@BIOTECHSCANNER Its alright buddy. I am hoping $IOVA will compensate for $AKRO and more πŸ˜€. Talking of MASH and GLP1s have you ever looked at $VKTX They have had real good data releases so far"
X Link 2025-10-17T03:30Z [---] followers, [---] engagements

"@jimcramer Hopefully $AirBnB is listening πŸ˜€"
X Link 2018-12-09T19:01Z [---] followers, [--] engagements

"@tarahaelle really enjoyed ur talk at nfid"
X Link 2019-04-05T13:17Z [---] followers, [--] engagements

"@ajitosu I will only buy SPACs close to the merger dates even if I like them. Too many just meander even though I like the management like $FCAC $HAAC $FTOC"
X Link 2021-06-18T17:56Z [---] followers, [--] engagements

"@ajitosu even direct listings want exposure to SPACs apparently:)πŸ˜€ Palantir $PLTR is actively investing in SPACs To date they have invested in nine SPACs: $CELU - Celularity (DeSPAC) $QELL - Lilium $RPT - Sarcos $MAAC - Roivant $VOSO - Vejo $KURI - Babylon $SVOK - Boxed $THMA - Pear $ENNV - Fast Radius Thanks for the idea @kingtutspacs https://t.co/ZgYGRqY2q3 Palantir $PLTR is actively investing in SPACs To date they have invested in nine SPACs: $CELU - Celularity (DeSPAC) $QELL - Lilium $RPT - Sarcos $MAAC - Roivant $VOSO - Vejo $KURI - Babylon $SVOK - Boxed $THMA - Pear $ENNV - Fast Radius"
X Link 2021-07-22T05:29Z [---] followers, [--] engagements

"@JonahLupton $NARI $SWAV both have tremendous potential"
X Link 2024-01-05T17:05Z [---] followers, [---] engagements

"@Pharmdca $LVGO has got to be one of the worst buys but another company. The write downs that $TDOC has had to do because of that one decision is absolutely insane"
X Link 2024-02-18T23:00Z [---] followers, [----] engagements

"@FitFounder Simple but powerful mental shift. This has to be a lifestyle choice as otherwise it becomes a part time activity which isnt as effective"
X Link 2025-02-21T15:55Z [---] followers, [--] engagements

"@BIOTECHSCANNER I believe these were the conclusions πŸ‘Œ"
X Link 2025-10-09T22:47Z [---] followers, [----] engagements

"@BIOTECHSCANNER What do you think about liquidity as they will most likely have to raise cash soon. I hope the data readouts will give them enough of a bump that they dont severely dilute shareholders"
X Link 2025-10-09T23:12Z [---] followers, [---] engagements

"@BIOTECHSCANNER Crazy ride for Orbital Tx after a massive Series A. Congrats to the company & I hope someday $IOVA will get the premiere price it deserves. These are not easy medications to manufacture and when the clinical outcomes look so strong BIG pharma can't just stay on the sidelines"
X Link 2025-10-10T16:18Z [---] followers, [---] engagements

"@BIOTECHSCANNER yeah I think I am beginning to get excited about this Ticker again after a long time. Stock price is certainly not reflecting the potential and value of its assets. Thanks for being a voice of reason and optimism on this one buddy"
X Link 2025-10-13T20:49Z [---] followers, [--] engagements

"@BIOTECHSCANNER Do we know if $IOVA has any plans to develop allogeneic TILs Off the shelf could be a huge vertical but I guess these initial readouts will pave the path for those later iterations"
X Link 2025-10-29T17:58Z [---] followers, [---] engagements

"@Brian_Stoffel_ Very undervalued company at the forefront of saving lives🫑"
X Link 2025-10-29T21:54Z [---] followers, [---] engagements

"@BIOTECHSCANNER This is where the bamboo analogy is so apt. Someday this one will see a violent move / takeover bid but in the meantime keep adding to your position. They have not [--] but [--] blockbuster treatments with readouts in the near future. Extremely Undervalued if the company can execute"
X Link 2025-11-03T20:44Z [---] followers, [--] engagements

"@TheRealDanSfera Maybe someday they will give a Nobel prize for this life saving modality. UnTILthen let $IOVA keep generating ground breaking therapies to counter solid malignanciesπŸ’ͺ"
X Link 2025-11-15T20:02Z [---] followers, [---] engagements

"@StockMarketNerd $RKLB"
X Link 2025-11-18T17:04Z [---] followers, [---] engagements

"go $AQST @BIOTECHSCANNER @Dansfera πŸ™ŒπŸ‘πŸ‘ŒπŸ₯° https://www.allergicliving.com/2025/11/24/aquestives-anaphylm-shows-positive-results-in-first-study-in-kids/ https://www.allergicliving.com/2025/11/24/aquestives-anaphylm-shows-positive-results-in-first-study-in-kids/"
X Link 2025-12-02T18:49Z [---] followers, [---] engagements

"@mvcinvesting The current valuation of some of the privately held companies is absolutely bonkers OpenAI is another one"
X Link 2025-12-05T21:20Z [---] followers, [---] engagements

"@marketplunger1 I hope its $IOVA"
X Link 2025-12-06T18:53Z [---] followers, [---] engagements

"@sweatystartup I have also heard the TG/HDL ratio is a better read. Have you also looked at your A1c and resting Insulin levels"
X Link 2025-12-16T20:45Z [---] followers, [--] engagements

"$AQST has the best in class product with huge potential to save human lives. It certianly deserves to get FDA approval given the strength of its clinical data package for a game changing intervention"
X Link 2025-12-17T04:03Z [---] followers, [---] engagements

"@BIOTECHSCANNER @Dansfera maybe they would like to also add anaphylm to their repertoire shortly πŸ˜€. Go $AQST https://www.fiercepharma.com/pharma/gsk-rounds-out-year-approvals-fda-asthma-nod-long-acting-biologic-exdensur https://www.fiercepharma.com/pharma/gsk-rounds-out-year-approvals-fda-asthma-nod-long-acting-biologic-exdensur"
X Link 2025-12-19T16:15Z [---] followers, [---] engagements

"@Pharmdca $IOVA"
X Link 2025-12-24T18:20Z [---] followers, [---] engagements

"@chitchatstocks @CCM_Brett Because $LLY is right behind them with the approval of their oral pill. The cost advantage for $LLY will far exceed due to it being a small molecule unlike $NVO that is a peptide. And $LLY will utilize this for maintenance once you have lost weight on zepbound"
X Link 2025-12-27T19:36Z [---] followers, [----] engagements

"@mvcinvesting That being said it can just be all about timing. $PLTR and many others like $HOOD come to mind"
X Link 2025-12-28T22:15Z [---] followers, [---] engagements

"@BIOTECHSCANNER Happy new year brother and hopefully $AQST will start the year with a bang. Such an amazing investment opportunity right in front with a life saving modality. $IOVA is my dark horse going into [----]. Both these have terrific managements now so time to execute now"
X Link 2025-12-31T17:33Z [---] followers, [---] engagements

"@BIOTECHSCANNER @Dansfera Excited about $IOVA while keeping an eye on the ever creeping competition I am getting intrigued by $IMTX data in melanoma and was wondering if you kind folks have looked into it deeply. I am generally averse to CAR-Ts but their data looks interesting"
X Link 2026-01-02T20:40Z [---] followers, [---] engagements

"@BIOTECHSCANNER @Dansfera I competely resonate with you sir. I also think if over the counter is coming then they do a lot better as a standalone company. Who wouldn't want this in place of clunky devices. So bullish for $AQST and these price could look ridiculous in [--] mo from now"
X Link 2026-01-07T22:11Z [---] followers, [---] engagements

"@AndrewDudum Any plans for re-negotiating with $NVO on selling Oral Wegovy on $HIMS Looks like its on many other platforms except $HIMS which is tragic"
X Link 2026-01-07T22:12Z [---] followers, [---] engagements

"@himshouse This $NVO fallout is hurting them materially. While the oral wegovy is getting sold at every online vendor $HIMS sits on the sidelines πŸ€·β™‚"
X Link 2026-01-09T16:25Z [---] followers, [----] engagements

"@BIOTECHSCANNER Great write up and thank you for continuing to be a voice of reason and logic. Today wasn't ideal but nothing changes (apart from a delay) in getting this important approval for $AQST. Stay patient and stay invested"
X Link 2026-01-09T23:48Z [---] followers, [---] engagements

"@MMatters22596 Its not about the past but the future and how dominant $LLY is in US. Plain and simple. Look at the velocity of their growth and you can understand why the market is giving it that multiple"
X Link 2026-01-10T19:22Z [---] followers, [---] engagements

"@Dansfera I am prepared to see a darn CRL but the investment thesis remains. It would be unfortunate but the end of the world. $AQST drug works and that's the most important bit"
X Link 2026-01-13T00:57Z [---] followers, [----] engagements

"@kainvests This one sure knows how to test an investor's patience but with an approval in the bag and more BIG news on the way I will remain patient. Hopefully [----] could be the turnaround year for $IOVA"
X Link 2026-01-13T15:06Z [---] followers, [---] engagements

"@kainvests Only way seems in the ring direction. The earnings cannot come soon enough to show how the execution is going"
X Link 2026-01-15T21:42Z [---] followers, [--] engagements

"@Dansfera Very well compiled summary Dan and I hope Claude is right. A [--] mo delay would Certianly suck but I am rooting for the management. No desire to trade even a single share as I do believe that the drug works and its about getting the label right Go $AQST"
X Link 2026-01-16T03:24Z [---] followers, [----] engagements

"@chitchatstocks $HIMS"
X Link 2026-01-16T05:33Z [---] followers, [---] engagements

"@BIOTECHSCANNER The silence on $AQST is difficult to understand given we are so close to PDUFA. How is it that FDA has cited them but then not provided any context for what the deficiencies might be"
X Link 2026-01-22T19:09Z [---] followers, [----] engagements

"New real world data from $IOVA. Higher response rates observed w/ lower disease burden & fewer prior lines of therapy. Clin benefit independent of infused TIL dose supporting efficacy not driven by IL-2 exposure No new safety signals or early mortality were observed. WOWπŸ‘"
X Link 2026-02-06T20:00Z [---] followers, [---] engagements

"@Pharmdca Looking at $NKTR I am even more bullish on $CRVS once they have ph2 data. Patience will pay off"
X Link 2026-02-12T21:49Z [---] followers, [---] engagements

"@BradoCapital $WIZEY"
X Link 2024-05-29T05:28Z [---] followers, [---] engagements

"@hubermanlab Jim Wassil COO Vaxcyte Inc as he has been instrumental in brining several vaccines against severe infant diseases to market. He has worked at major pharma companies and is a wealth of knowledge in this space"
X Link 2025-02-23T00:38Z [---] followers, [--] engagements

"@dpolehn Currently at 5-7 reps @ 150-160lb range but would be amazing if I could hit around 180lb+ by year end"
X Link 2026-01-02T17:19Z [---] followers, [--] engagements

"@BIOTECHSCANNER Viatris would be the obvious but I hope $GSK would like to acquire this asset to stay competitive in the anti-allergen space https://aquestive.com/about-us/team/sherry-korczynski/ https://aquestive.com/about-us/team/sherry-korczynski/"
X Link 2026-01-05T17:15Z [---] followers, [---] engagements

"@Pharmdca $MDGL and $VKTX would complete both parts of targeting obesity and MASH"
X Link 2026-01-27T01:24Z [---] followers, [---] engagements

"@HOThomasWPhelps market is discounting the potential for what $CRVS has. I am a buyer"
X Link 2026-01-29T22:31Z [---] followers, [---] engagements

"@BIOTECHSCANNER Fantastic to see these patient success stories. Someday the market will rise to the moat that $IOVA is building. TILs have the potential to revolutionize cancer treatment against solid malignancies"
X Link 2026-02-04T19:49Z [---] followers, [---] engagements

"@Pharmdca Hard to understand $NVOs strategy to not have a single GLP-1/GIP asset. They think amylin will save them but looks unlikely"
X Link 2026-02-05T22:59Z [---] followers, [---] engagements

"@Pharmdca Yes $LLY will continue to dominate unless $NVO can develop a more potent asset. $VKTX looks so undervalued here given the data readouts in the near future"
X Link 2026-02-08T18:15Z [---] followers, [---] engagements

"@BIOTECHSCANNER This is an execution story for me. The drug works which is massive but the numbers need to meet their guidance. They have made terrible mistakes in the past but hopefully we are off to greener pastures now"
X Link 2026-02-12T21:45Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing